• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

AstraZeneca

Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o
Biotech

AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders

AstraZeneca adds FDA cell and gene veteran. Corrixr founder passes baton to new CEO. Capricor brings in DMD veteran to lead commercial launch.
Darren Incorvaia , Zoey Becker , Will Maddox Jun 5, 2026 8:30am
Berlin Germany Brandenburg Gate
Favicon Fierce Pharma

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm
ASCO

ASCO: BMS' bispecific ADC puts TROP2 drugs on notice

Jun 2, 2026 8:00am
success failure signposts

AstraZeneca, after phase 3 miss, posts data behind approval bid

May 29, 2026 10:15am
AZ

FDA delays ruling on AstraZeneca drug after negative adcomm vote

May 27, 2026 4:43am
A doctor with black painted nails types on a sleek keyboard that is next to a stethoscope

AstraZeneca pens agentic AI licensing deal with Owkin

May 13, 2026 2:06am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings